7-128028018-C-T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_022143.5(LRRC4):​c.*661G>A variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.11 in 152,726 control chromosomes in the GnomAD database, including 1,187 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 1186 hom., cov: 32)
Exomes 𝑓: 0.10 ( 1 hom. )

Consequence

LRRC4
NM_022143.5 3_prime_UTR

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.00400

Publications

8 publications found
Variant links:
Genes affected
LRRC4 (HGNC:15586): (leucine rich repeat containing 4) Predicted to be involved in modulation of chemical synaptic transmission and synapse organization. Predicted to act upstream of or within synapse organization. Predicted to be located in neuron spine and postsynaptic membrane. Predicted to be active in Schaffer collateral - CA1 synapse; glutamatergic synapse; and plasma membrane. Predicted to be integral component of postsynaptic density membrane. [provided by Alliance of Genome Resources, Apr 2022]
SND1 (HGNC:30646): (staphylococcal nuclease and tudor domain containing 1) This gene encodes a transcriptional co-activator that interacts with the acidic domain of Epstein-Barr virus nuclear antigen 2 (EBNA 2), a transcriptional activator that is required for B-lymphocyte transformation. Other transcription factors that interact with this protein are signal transducers and activators of transcription, STATs. This protein is also thought to be essential for normal cell growth. A similar protein in mammals and other organisms is a component of the RNA-induced silencing complex (RISC). [provided by RefSeq, Jul 2016]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.208 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRRC4NM_022143.5 linkc.*661G>A 3_prime_UTR_variant Exon 2 of 2 ENST00000249363.4 NP_071426.1 Q9HBW1
SND1NM_014390.4 linkc.1779+36962C>T intron_variant Intron 16 of 23 ENST00000354725.8 NP_055205.2 Q7KZF4A0A140VK49
LRRC4XM_011516461.4 linkc.*661G>A 3_prime_UTR_variant Exon 3 of 3 XP_011514763.1 Q9HBW1
LRRC4XM_047420695.1 linkc.*661G>A 3_prime_UTR_variant Exon 3 of 3 XP_047276651.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRRC4ENST00000249363.4 linkc.*661G>A 3_prime_UTR_variant Exon 2 of 2 1 NM_022143.5 ENSP00000249363.3 Q9HBW1
SND1ENST00000354725.8 linkc.1779+36962C>T intron_variant Intron 16 of 23 1 NM_014390.4 ENSP00000346762.3 Q7KZF4

Frequencies

GnomAD3 genomes
AF:
0.110
AC:
16660
AN:
152142
Hom.:
1181
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0469
Gnomad AMI
AF:
0.0965
Gnomad AMR
AF:
0.213
Gnomad ASJ
AF:
0.155
Gnomad EAS
AF:
0.0779
Gnomad SAS
AF:
0.176
Gnomad FIN
AF:
0.110
Gnomad MID
AF:
0.0886
Gnomad NFE
AF:
0.120
Gnomad OTH
AF:
0.111
GnomAD4 exome
AF:
0.103
AC:
48
AN:
466
Hom.:
1
Cov.:
0
AF XY:
0.109
AC XY:
30
AN XY:
276
show subpopulations
African (AFR)
AC:
0
AN:
0
American (AMR)
AF:
0.500
AC:
1
AN:
2
Ashkenazi Jewish (ASJ)
AC:
0
AN:
0
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2
South Asian (SAS)
AC:
0
AN:
0
European-Finnish (FIN)
AF:
0.100
AC:
42
AN:
418
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.132
AC:
5
AN:
38
Other (OTH)
AF:
0.00
AC:
0
AN:
6
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
3
5
8
10
13
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.110
AC:
16684
AN:
152260
Hom.:
1186
Cov.:
32
AF XY:
0.113
AC XY:
8407
AN XY:
74450
show subpopulations
African (AFR)
AF:
0.0468
AC:
1945
AN:
41540
American (AMR)
AF:
0.214
AC:
3270
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.155
AC:
538
AN:
3472
East Asian (EAS)
AF:
0.0776
AC:
403
AN:
5190
South Asian (SAS)
AF:
0.177
AC:
855
AN:
4826
European-Finnish (FIN)
AF:
0.110
AC:
1164
AN:
10608
Middle Eastern (MID)
AF:
0.0952
AC:
28
AN:
294
European-Non Finnish (NFE)
AF:
0.120
AC:
8154
AN:
68010
Other (OTH)
AF:
0.113
AC:
239
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
764
1528
2293
3057
3821
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
192
384
576
768
960
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.114
Hom.:
1658
Bravo
AF:
0.114
Asia WGS
AF:
0.149
AC:
516
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
8.1
DANN
Benign
0.67
PhyloP100
-0.0040
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3808058; hg19: chr7-127668071; API